Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients

Ayalew Tefferi, Thitina Jimma, Naseema Gangat, Rakhee Vaidya, Kebede H. Begna, Curtis A. Hanson, Daniel L. Van Dyke, Domenica Caramazza and Animesh Pardanani

Article Information

vol. 118 no. 17 4595-4598

Print ISSN 
Online ISSN 
  • Submitted July 29, 2011
  • Accepted August 22, 2011
  • Published online October 27, 2011.

Article Versions

  • Ayalew Tefferi, Divisions of 1Hematology,
  • Thitina Jimma, Divisions of 1Hematology,
  • Naseema Gangat, Divisions of 1Hematology,
  • Rakhee Vaidya, Divisions of 1Hematology,
  • Kebede H. Begna, Divisions of 1Hematology,
  • Curtis A. Hanson, 2Hematopathology, and
  • Daniel L. Van Dyke, 3Cytogenetics, Mayo Clinic, Rochester, MN; and
  • Domenica Caramazza, 4Division of Hematology, Department of Internal Medicine, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
  • Animesh Pardanani, Divisions of 1Hematology, Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output